A groundbreaking therapy, retatrutide, is sparking significant buzz within the weight-loss community as a potential breakthrough for stubborn weight problems. This new drug, a dual receptor targeting glucagon-like peptide-1 and another hormone, appears to exhibit significant efficacy in clinical studies, potentially contributing to noticeable weigh